Wang A - Search Results

1

The 12-year follow-up of survival, chronic adverse effects, and retention of arsenic in patients with acute promyelocytic leukemia.

Zhu H, Hu J, Chen L, Zhou W, Li X, Wang L, Zhao X, Zhang Y, Zhao H, Wang A, Chen Y, Sun H, Chen Q, Chen Y, Zhao W, Mi J, Shen Z, Wang Z, Chen Z, Chen S, Li J. Zhu H, et al. Among authors: wang l, wang z, wang a. Blood. 2016 Sep 15;128(11):1525-8. doi: 10.1182/blood-2016-02-699439. Epub 2016 Jul 11. Blood. 2016. PMID: 27402972 Free article. No abstract available.

2

[Clinical observation of the short-term efficacy of the treatment with combination of all-trans retinoic acid (ATRA) and arsenic trioxide (As2O3) in newly diagnosed acute promyelocytic leukemia (APL)].

Liu YF, Shen ZX, Chen X, Wang AH, Cao Q, Zhu YM, Chen SJ, Chen Z, Wang ZY. Liu YF, et al. Zhonghua Xue Ye Xue Za Zhi. 2003 Jan;24(1):25-7. Zhonghua Xue Ye Xue Za Zhi. 2003. PMID: 12679006 Chinese.

3

Summary of 615 patients of chronic myeloid leukemia in Shanghai from 2001 to 2006.

Wang AH, Wang YY, Yao Y, Xu ZZ, Zhou L, Wang L, Zhang L, Chen Y, Shen ZX, Hu J, Li JM. Wang AH, et al. J Exp Clin Cancer Res. 2010 Mar 3;29(1):20. doi: 10.1186/1756-9966-29-20. J Exp Clin Cancer Res. 2010. PMID: 20199658 Free PMC article.

4

Synergistic effect of bortezomib and valproic acid treatment on the proliferation and apoptosis of acute myeloid leukemia and myelodysplastic syndrome cells.

Wang AH, Wei L, Chen L, Zhao SQ, Wu WL, Shen ZX, Li JM. Wang AH, et al. Ann Hematol. 2011 Aug;90(8):917-31. doi: 10.1007/s00277-011-1175-6. Epub 2011 Feb 22. Ann Hematol. 2011. PMID: 21340723

5

Pregnancies in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitor.

Zhou L, You JH, Wu W, Li JM, Shen ZX, Wang AH. Zhou L, et al. Leuk Res. 2013 Oct;37(10):1216-21. doi: 10.1016/j.leukres.2013.07.020. Epub 2013 Aug 12. Leuk Res. 2013. PMID: 23937984

6

[Efficacy and safety of imatinib in treatment of 151 chronic myeloid leukemia patients].

Zhou L, Wang AH, Wang L, You JH, Li JM, Shen ZX. Zhou L, et al. Zhonghua Xue Ye Xue Za Zhi. 2008 Jan;29(1):13-7. Zhonghua Xue Ye Xue Za Zhi. 2008. PMID: 18512309 Chinese.

7

[Prognostic significance of Ph-positive acute lymphoblastic leukemia].

Zhou L, Hu J, Chen J, Du S, Wang A, You J, Wu W, Shen Z, Li J. Zhou L, et al. Among authors: wang a. Zhonghua Xue Ye Xue Za Zhi. 2014 Feb;35(2):109-13. doi: 10.3760/cma.j.issn.0253-2727.2014.02.011. Zhonghua Xue Ye Xue Za Zhi. 2014. PMID: 24606650 Chinese.

8

[Detection and quantification of BCR-ABL transcripts in patients with chronic myeloid leukemia by real-time quantitative reverse transcriptase polymerase chain reaction].

Xing W, Gu BW, Zhu YM, Jiang CL, Zhao RH, Wang AH, Sun HP, Li JM, Shen ZX, Chen Z, Chen SJ. Xing W, et al. Zhonghua Yi Xue Za Zhi. 2005 Feb 23;85(7):453-7. Zhonghua Yi Xue Za Zhi. 2005. PMID: 15854550 Chinese.

9

[Nilotinib treatment for imatinib resistant or intolerant chronic myelogenous leukemia.].

Wang AH, Zhou L, You JH, Wang L, Li JM, Hu J, Shen ZX. Wang AH, et al. Zhonghua Xue Ye Xue Za Zhi. 2010 Jan;31(1):11-5. Zhonghua Xue Ye Xue Za Zhi. 2010. PMID: 20302768 Chinese.

10

Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma.

Wang L, Shi WY, Wu ZY, Varna M, Wang AH, Zhou L, Chen L, Shen ZX, Lu H, Zhao WL, Janin A. Wang L, et al. Among authors: wang ah. J Hematol Oncol. 2010 Sep 9;3:30. doi: 10.1186/1756-8722-3-30. J Hematol Oncol. 2010. PMID: 20828385 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,596 results

Search Page

Filters